fda compounding semaglutide news today 2025 Intensifies Crackdown on GLP-1 FDA Ban on Compounded GLP-1

These companies currently offer five GLP-1 drugs approved for type 2 diabetes, with four also approved for various cardiovascular conditions

Not only do they can they stimulate the production and release of your own bodys growth hormone, but they are able to do so in a way that is safe and complementary with one another

It's modeled after a certain part of the human growth hormonethe part theorized to tell your body to burn fat

Unlike injections, which go directly into the bloodstream, the tablets must first be digested

Its triple receptor mechanism means it changes glucose regulation, gastric motility, and body weight in ways that ripple through how other medications work

Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from dual agonists such as tirzepatide and single agonists such as semaglutide